These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28125179)

  • 41. [Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease].
    Pondel J; Krajewski P; Królikowska N; Tobiasz A; Augustyniak-Bartosik H; Hurkacz M
    Pol Merkur Lekarski; 2017 Apr; 42(250):145-150. PubMed ID: 28530212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vancomycin dosing in chronic high-flux haemodialysis: a systematic review.
    Hui K; Upjohn L; Nalder M; Buising K; Pedagogos E; Nelson C; Kirkpatrick CMJ; Kong DCM
    Int J Antimicrob Agents; 2018 May; 51(5):678-686. PubMed ID: 29284156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Ghouti-Terki L; Chasseuil E; Rabot N; Paintaud G; François M; Birmelé B; Darrouzain F; Büchler M; Halimi JM; Ternant D
    Nephron; 2017; 135(4):261-267. PubMed ID: 28152540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
    Allawati H; Dallas L; Nair S; Palmer J; Thaikandy S; Hutchison C
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32408589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of vancomycin in critically ill patients undergoing continuous venovenous haemodialysis.
    Chaijamorn W; Wanakamanee U
    Int J Antimicrob Agents; 2014 Oct; 44(4):367-8. PubMed ID: 25127656
    [No Abstract]   [Full Text] [Related]  

  • 46. Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.
    Guilhaumou R; Marsot A; Dupouey J; Galambrun C; Boulamery A; Coze C; Simon N; André N
    Ther Drug Monit; 2016 Oct; 38(5):559-66. PubMed ID: 27631462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion.
    De Waele JJ; Danneels I; Depuydt P; Decruyenaere J; Bourgeois M; Hoste E
    Int J Antimicrob Agents; 2013 May; 41(5):434-8. PubMed ID: 23410793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients.
    Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E
    J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
    Beibei L; Yun C; Mengli C; Nan B; Xuhong Y; Rui W
    Int J Antimicrob Agents; 2010 Jan; 35(1):3-12. PubMed ID: 19900794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of vancomycin in dialysis patients.
    Saghafi D
    Clin Nephrol; 1996 May; 45(5):366. PubMed ID: 8738678
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain].
    Grau S; Rebollo P; Cuervo J; Gil-Parrado S
    Rev Esp Quimioter; 2011 Sep; 24(3):154-63. PubMed ID: 21947099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.
    Chaftari AM; Hachem R; Jordan M; Garoge K; Al Hamal Z; El Zakhem A; Viola GM; Granwehr B; Mulanovich V; Gagel A; Reitzel R; Yousif A; Jiang Y; Raad I
    Antimicrob Agents Chemother; 2016 Jan; 60(1):239-44. PubMed ID: 26482312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors and clinical outcomes for vancomycin-resistant enterococcus bacteraemia in hospitalised cancer patients in Pakistan: A case-control study.
    Akhtar N; Sultan F; Nizamuddin S; Zafar W
    J Pak Med Assoc; 2016 Jul; 66(7):829-36. PubMed ID: 27427131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
    Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
    Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial.
    Rijnders BJ; Van Wijngaerden E; Vandecasteele SJ; Stas M; Peetermans WE
    J Antimicrob Chemother; 2005 Jan; 55(1):90-4. PubMed ID: 15574481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
    Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the pharmacodynamic profile of commonly used intravenous vancomycin dosing schemes in patients on automated peritoneal dialysis.
    Cardone KE; Chen WZ; Grabe DW; Batzold A; Manley HJ; Lodise TP
    J Antimicrob Chemother; 2014 Jul; 69(7):1873-6. PubMed ID: 24722842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
    Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
    Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
    Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
    Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vancomycin Removal During High-Volume Peritoneal Dialysis in Acute Kidney Injury Patients.
    Ponce D; Zamoner W; Freitas FM; Balbi A; Awdishu L
    Perit Dial Int; 2019; 39(2):183-187. PubMed ID: 30858287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.